Zhaohui Jin

4.4k total citations · 1 hit paper
138 papers, 3.0k citations indexed

About

Zhaohui Jin is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Zhaohui Jin has authored 138 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 46 papers in Surgery and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Zhaohui Jin's work include Colorectal Cancer Treatments and Studies (29 papers), Genetic factors in colorectal cancer (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers). Zhaohui Jin is often cited by papers focused on Colorectal Cancer Treatments and Studies (29 papers), Genetic factors in colorectal cancer (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers). Zhaohui Jin collaborates with scholars based in United States, China and Japan. Zhaohui Jin's co-authors include Frank A. Sinicrope, Xianhua Piao, Xingming Deng, Fengqin Gao, Klaus Kluck, Jan Budczies, Dan Sha, Albrecht Stenzinger, Tammy Flagg and Rong Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Zhaohui Jin

124 papers receiving 2.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

2020 510 citations Dan Sha, Zhaohui Jin et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhaohui Jin United States	27	1.3k	1.1k	585	466	420	138	3.0k
Keiji Hirata Japan	28	1.2k 0.9×	1.1k 1.0×	402 0.7×	333 0.7×	668 1.6×	189	2.8k
Qin Li China	31	1.1k 0.9×	1.3k 1.2×	1.2k 2.0×	553 1.2×	495 1.2×	154	3.9k
Eric J. Kort United States	26	1.3k 1.0×	606 0.5×	583 1.0×	474 1.0×	331 0.8×	55	2.4k
Michael Höpfner Germany	29	1.2k 0.9×	623 0.6×	419 0.7×	384 0.8×	257 0.6×	64	2.5k
Luca Messerini Italy	35	1.0k 0.8×	1.1k 1.0×	729 1.2×	467 1.0×	889 2.1×	113	3.7k
Gang Zhao China	33	1.5k 1.2×	656 0.6×	640 1.1×	631 1.4×	514 1.2×	155	3.4k
József Tóvári Hungary	29	1.7k 1.3×	1.1k 1.0×	395 0.7×	613 1.3×	300 0.7×	143	3.1k
Bin Zhang China	27	872 0.7×	354 0.3×	460 0.8×	280 0.6×	246 0.6×	187	2.6k
Risto Kerkelä Finland	31	2.0k 1.6×	1.1k 1.0×	621 1.1×	336 0.7×	536 1.3×	86	4.6k
Olivier Dormond Switzerland	33	1.7k 1.4×	1.1k 1.0×	323 0.6×	584 1.3×	260 0.6×	72	3.3k

Countries citing papers authored by Zhaohui Jin

Since Specialization

Citations

This map shows the geographic impact of Zhaohui Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaohui Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaohui Jin more than expected).

Fields of papers citing papers by Zhaohui Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaohui Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaohui Jin. The network helps show where Zhaohui Jin may publish in the future.

Co-authorship network of co-authors of Zhaohui Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaohui Jin. A scholar is included among the top collaborators of Zhaohui Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaohui Jin. Zhaohui Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Naqvi, Syed Arsalan Ahmed, Zhaohui Jin, Harry H. Yoon, et al.. (2025). Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis. The Oncologist. 30(8). 2 indexed citations

Chakrabarti, Sakti, et al.. (2025). Safety and Efficacy of Anti–Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review. JCO Precision Oncology. 9(9). e2400594–e2400594.

Selfridge, J. Eva, Christopher L. Hallemeier, Krishan R. Jethwa, et al.. (2024). Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer. Cancers. 16(13). 2407–2407. 1 indexed citations

Jin, Zhaohui, Kathryn J. Ruddy, Deirdre R. Pachman, et al.. (2024). Symptom burden in adolescents and young adults with cancer: A subgroup analysis of the enhanced, EHR-facilitated cancer symptom control (E2C2) trial.. Journal of Clinical Oncology. 42(16_suppl). 12065–12065.

Zemla, Tyler, Jennifer Gile, Nguyen H. Tran, et al.. (2024). Atezolizumab plus bevacizumab (A+B) as first-line systemic therapy for advanced hepatocellular carcinoma (HCC): A multi-institution analysis of patient outcomes based on Child Pugh (CP) and ALBI liver function.. Journal of Clinical Oncology. 42(16_suppl). 4099–4099. 1 indexed citations

Kurniali, Peter C., et al.. (2023). Targeted Therapies in Advanced Cholangiocarcinoma. Life. 13(10). 2066–2066. 7 indexed citations

Perets, Ruth, Salomon M. Stemmer, Ravit Geva, et al.. (2023). 161TiP A phase I/II, open-label study of an anti-ILT2 (LILRB1) antibody, SAR444881, administered alone and in combination with pembrolizumab, with or without chemotherapy, or cetuximab in patients with advanced solid tumors. Immuno-Oncology Technology. 20. 100672–100672. 1 indexed citations

Kamath, Suneel D., David Tai, Irene Moreno, et al.. (2023). Abstract OT3-24-01: ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer. Cancer Research. 83(5_Supplement). OT3–24.

Buckarma, EeeLN H., Cornelius A. Thiels, Zhaohui Jin, & Travis E. Grotz. (2023). Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis. Annals of Surgical Oncology. 31(1). 622–629. 8 indexed citations

10.

Tella, Sri Harsha, Nathan R. Foster, Qian Shi, et al.. (2023). Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma. The Oncologist. 28(10). 917–e966. 1 indexed citations

11.

Zemla, Tyler, Robert R. McWilliams, Frank A. Sinicrope, et al.. (2023). A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 227–227. 1 indexed citations

12.

Saberzadeh-Ardestani, Bahar, Jeremy Jones, Joleen M. Hubbard, et al.. (2023). Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab. JAMA Network Open. 6(2). e230400–e230400. 27 indexed citations

13.

Tella, Sri Harsha, Kristin C. Mara, Sakti Chakrabarti, Zhaohui Jin, & Amit Mahipal. (2023). A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data. Journal of Gastrointestinal Oncology. 14(1). 1–10. 6 indexed citations

14.

Lin, Hong, et al.. (2023). Association between Serum Uric Acid and Liver Enzymes in Adults Aged 20 Years and Older in the United States: NHANES 2005–2012. Journal of Clinical Medicine. 12(2). 648–648. 1 indexed citations

15.

Gile, Jennifer, Fang‐Shu Ou, Amit Mahipal, et al.. (2021). FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO Precision Oncology. 5(5). 1228–1240. 6 indexed citations

16.

Childs, Daniel S., et al.. (2020). Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Supportive Care in Cancer. 29(2). 733–739. 3 indexed citations

17.

Sha, Dan, Zhaohui Jin, Jan Budczies, et al.. (2020). Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors. Cancer Discovery. 10(12). 1808–1825. 510 indexed citations breakdown →

18.

Jin, Zhaohui, William R. Sukov, Christopher A. Sattler, et al.. (2018). Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma. American Journal of Clinical Oncology. 42(2). 190–195. 2 indexed citations

19.

Fan, Ping, et al.. (2018). Recent progress and market analysis of anticoagulant drugs. Journal of Thoracic Disease. 10(3). 2011–2025. 35 indexed citations

20.

Luo, Rong, Sung‐Jin Jeong, Zhaohui Jin, et al.. (2011). G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination. Proceedings of the National Academy of Sciences. 108(31). 12925–12930. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact